Plasma 25-hydroxyvitamin D levels and survival in stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance)
- Citation:
- Clin Cancer Res vol 29 (14) 2621-2630
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 12
- Parents:
- 3714
- Children:
- None
- Pharmas:
- Pfizer
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA189858, UG1CA189960, UG1CA233163, UG1CA233180, UG1 CA233320, UG1CA233290, UG1CA233337, UG1CA233339; UG1CA233234, U10CA180863, CCS Grant # 707213(CCTG); U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888, UG1CA233163(SWOG), R01CA205406, R33CA160344, P30 CA008748, P30 CA015083
- Corr. Author:
- Authors:
- Qiao-Li Wang Chao Ma Chen Yuan Qian Shi Brian M. Wolpin Yin Zhang Charles S. Fuchs Jeffrey Meyer Tyler Zemla En Cheng Priya Kumthekar Katherine A. Guthrie Felix Couture Philip Kuebler Pankaj Kumar Benjamin Tan Smitha Krishnamurthi Richard M. Goldberg Alan Venook Charles Blanke Anthony F. Shields Eileen M. O'Reilly Jeffrey A. Meyerhardt Kimmie Ng
- Networks:
- CA136, HEARTLAND, LAPS-CT018, LAPS-IL036, LAPS-MA036, LAPS-MD017, LAPS-MO011, LAPS-NY016, LAPS-OH007, OH027, OR013
- Study
- Alliance-A151939
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80702
- Phases:
- N/A, 3
- Keywords:
- colon adenocarcinoma, recurrence, survival, 25(OH)D, inflammation, biomarker